Diabetes

A systematic review of the impact and rationale for the selection of adjustment factors (case-mix factors) used to describe performance in diabetes care.

Researchers found that physicians often seized the "opportunity" to start dialysis if patients were in the hospital for other illnesses.

Top managed care stories this week included UnitedHealth reporting larger-than-expected losses on Affordable Care Act health plans, new guidelines from the government that will improve patient access to medical records, and new information that can reduce risk of diabetes.

The profile of high-cost patients in a Massachusetts ACO differed greatly, depending on their enrollment in Medicare, Medicaid, or a commercial plan.

The program seeks to reach an estimated 86 million Americans who have prediabetes, almost all whom don't know they have it.

A pocket veto ends hopes of Medicaid coverage for the Diabetes Prevention Program, MannKind partners with a pain medication manufacturer, and Governor Terry Branstad finds more Medicaid managed care woes.

More that a year after Congress first delayed upcoming rules on salt and whole grains, a new agreement takes the rougher edges off the school lunch program while preserving current limits on sodium. But it opens the door for a lobbying frenzy at USDA on "a la carte" foods.

The University of Colorado study adds to the growing concern that sleep deprivation is connected to rising rates of diabetes and obesity.

Black patients tend to have higher rates of hyperglycemia and diabetes compared with white patients. However, the factors that contribute to such racial disparities in the hospital in diabetes-related conditions are still not clear.

Two new studies highlight different approaches to cut sugar intake through soda for children and adults in an attempt to reduce overweight and obesity.

Warning labels on soda might have less consumer resistance than taxes or portion limits, the study found.

All this week, the healthcare industry, especially analysts and investors, focused their attention on presentations by CEOs and CFOs at the 34th annual JP Morgan Healthcare Conference.

A proposal to reduce Medicare Part B payment rates for hospitals participating in the 340B Drug Pricing Program has been approved 14-3 by the Medicare Payment Advisory Commission.

Access to testing for early diagnosis of chronic conditions, and use of data to find care gaps, will reduce health disparities.

Last year, an FDA advisory panel called for an updated label for saxagliptin, but the agency is still gathering information.

Rates of uninsured dropped faster than almost anywhere in the nation, but Kynect is part of "Obamacare," and the new Republican Governor Matt Bevin has vowed that it must go. Advocates have a lot of questions about how hard-to-target populations will be reached and whether grant funds will have to be repaid.

The kit began with a petition from an 11-year-old girl with T1D who wanted a doll that looked "just like me."

The state's new secretary of Health and Hospitals said she will need to hire 248 workers to replace those let go under former Governor Bobby Jindal if her agency is to enroll all those expected to pursue coverage under expansion.

The principal investigator at Seattle Children's said prior work has shown that intensive interventions can be effective in fighting obesity, but they are rarely covered by insurance.

The latest developments across the healthcare landscape and key upcoming conferences to attend.

Researchers examine the policy of taxing unhealthy foods and drinks in order to reduce rates of obesity, diabetes, hypertension, and other conditions linked to poor eating habits.

A recent safety trial has found a promising new therapy for type 1 diabetes that uses patients’ own regulatory T-cells instead of the usual immunosuppressive drugs to protect beta cells.

Top managed care stories include Sanofi ending its deal to market Afrezza, Aetna cut ties with America's Health Insurance Plans, and a new study found bankruptcy looms large for cancer survivors.

The guidelines show the influence of lobbyists, raising questions about how they will be created in future cycles. They will next be updated in 2020.

Analyzing factors associated with continuing care participation in patients with diabetes and with interrupted participation by patients enrolled in a diabetes pay-for-performance program.